Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11498967 CD80 variant immunomodulatory proteins and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
ALPINE IMMUNE SCIENCES, INC.
Date Filed
February 2, 2022
Date of Patent
November 15, 2022
Patent Applicant
‌
ALPINE IMMUNE SCIENCES, INC.
Patent Application Number
17591499
Patent Citations
‌
US Patent 11117949 CD80 variant immunomodulatory proteins and uses thereof
‌
US Patent 11078282 CD80 variant immunomodulatory proteins and uses thereof
‌
US Patent 11096988 CD80 variant immunomodulatory proteins and uses thereof
‌
US Patent 11117948 CD80 variant immunomodulatory proteins and uses thereof
‌
US Patent 11117950 CD80 variant immunomodulatory proteins and uses thereof
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11498967
Patent Primary Examiner
‌
Gary B. Nickol

Find more entities like US Patent 11498967 CD80 variant immunomodulatory proteins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.